112RO Subsequent anti-cancer therapy (SACT) of patients (pts) with newly diagnosed advanced ovarian cancer (AOC) in ATHENA-MONO/GOG-3020/ENGOT-ov45

E. Prendergast; V. Salutari; T-E. Ciuleanu; J.N. Barlin; M.P. Martinez Del Prado; J-W. Kim; B. Pothuri; F. Zagouri; V. Shirinkin; S. Westin; O. Kuru; M. Bobinski; T. Van Gorp; K. Weber; M. Craib; K. Fujiwara; B.J. Monk; R. Kristeleit

doi:10.1016/j.esmoop.2026.108159

Back

112RO Subsequent anti-cancer therapy (SACT) of patients (pts) with newly diagnosed advanced ovarian cancer (AOC) in ATHENA-MONO/GOG-3020/ENGOT-ov45

Journal article

Peer reviewed

112RO Subsequent anti-cancer therapy (SACT) of patients (pts) with newly diagnosed advanced ovarian cancer (AOC) in ATHENA-MONO/GOG-3020/ENGOT-ov45

E. Prendergast, V. Salutari, T-E. Ciuleanu, J.N. Barlin, M.P. Martinez Del Prado, J-W. Kim, B. Pothuri, F. Zagouri, V. Shirinkin, S. Westin, …

ESMO open, Vol.11, p.108159

07/2026

DOI: https://doi.org/10.1016/j.esmoop.2026.108159

Files and links (1)

url

https://doi.org/10.1016/j.esmoop.2026.108159View

Published (Version of record) Open

Metrics

1 Record Views

Details

Title: 112RO Subsequent anti-cancer therapy (SACT) of patients (pts) with newly diagnosed advanced ovarian cancer (AOC) in ATHENA-MONO/GOG-3020/ENGOT-ov45
Creators: E. Prendergast - LDS Hospital
V. Salutari - MITO and Department of Gynaecological Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
T-E. Ciuleanu - Department of Medical Oncology, IOCN - The Oncology Institute Prof. Dr. Ion Chiricuta, Cluj-Napoca, Romania
J.N. Barlin - Department of Gynaecological Oncology, Women's Cancer Care Associates, Albany, United States of America
M.P. Martinez Del Prado - GEICO and Medical Oncology Department, Hospital Universitario de Basurto, Bilbao, Spain
J-W. Kim - Seoul National University Hospital
B. Pothuri - NYU Langone’s Laura and Isaac Perlmutter Cancer Center
F. Zagouri - HeCOG and Clinical Therapeutics, General Hospital Konstantopoulio-Agia Olga, Athens, Greece
V. Shirinkin - Clinical Oncology, Orenburg Regional Clinical Oncological Dispensary, Orenburg, Russian Federation
S. Westin - Department of Gynaecological Oncology and Reproductive Medicine, The MD Anderson Cancer Center, Houston, United States of America
O. Kuru - TRSGO and Department of Gynecological Oncology, Istanbul University-Cerrahpasa - Faculty of Medicine, Istanbul, Türkiye
M. Bobinski - Medical University of Lublin
T. Van Gorp - BGOG and Division of Gynaecological Oncology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium
K. Weber - Medical Affairs, pharma& GmbH (pharma&), Vienna, Austria
M. Craib - Biometrics and Data Management, pharma& U.S., Inc., New York, United States of America
K. Fujiwara - Administration Office, Global Oncology Trials Japan, General Incorporated Foundation, Minato-Ku, Japan
B.J. Monk - Gynecologic Oncology Group
R. Kristeleit - Guy's and St Thomas' NHS Foundation Trust
Publication Details: ESMO open, Vol.11, p.108159
Publisher: Elsevier Ltd
Identifiers: 991006292257102656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article